[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 16, Issue 2 (2-2014) ::
J Babol Univ Med Sci. 2014; Volume 16 Back to browse issues page
Comparison of the Effect of Various Products of Erythropoietin on Hemoglobin Level in Hemodialysis Patients
HR Omrani , H Bashiri * , D Reissi Dastgerdi , F Najafi , SH Shafiezadeh , N Izadi
Abstract:   (7883 Views)
BACKGROUND AND OBJECTIVE: Normochromic-normocytic anemia is a common problem in patients with chronic renal failure. The main cause of anemia in such patients is insufficient production of erythropoietin by kidneys. This study was aimed to compare the effect of different products of erythropoietin on hemoglobin level in hemodialysis patients.
METHODS: In this Cohort study, 126 hemodialysis patients with hemoglobin less than 11 g/dl from Imam Reza and Imam Khomeini hospitals of Kermanshah, Iran were included. They received subcutaneous EXI poietin (65 patients) or PDpoietin (61 patients), 50-100 unit/Kg in three divided doses per week and followed up for two months and the results were compared in two groups with respect to changes in hemoglobin level and blood pressure after treatment.
FINDINGS: The mean increase in hemoglobin levels in EXIpoietin group was 0.16±1.5 and in PDpoietin group was 0.99±1.4 g/dl (p=0.02). Despite no statistically significant difference between mean hemoglobin level before treatment in two groups, after treatment the mean changes in PDpoietin group (0.99±1.4) was rather than EXIpoietin group (0.16±1.5). However, increase in blood pressure at the end of two months, was more in EXIpoietin group (systolic=8.32±6.04, diastolic=8.45±6.89) than the PDpoietin group (systolic=4.38±7.09, diastolic=4.36±5.63) (p<0.05).
CONCLUSION: The result showed that increase in hemoglobin level is greater in PDpoietin. Because the PDpoietin is more available with lower cost, it is recommended to use it for treatment of anemia in patients with hemodialysis.

Please cite this article as follows:
Omrani HR, Bashiri H, Reissi Dastgerdi D, Najafi F, Shafiezadeh SH, Izadi N. Comparison of the effect of various products of erythropoietin on hemoglobin level in hemodialysis patients. J Babol Univ Med Sci 2014 16(2): 23-28.
Keywords: EXIpoietin, PDpoietin, Hemodialysis, Hemoglobin, Anemia.
Full-Text [PDF 359 kb]   (7392 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/7 | Published: 2014/06/7



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Omrani H, Bashiri H, Reissi Dastgerdi D, Najafi F, Shafiezadeh S, Izadi N. Comparison of the Effect of Various Products of Erythropoietin on Hemoglobin Level in Hemodialysis Patients. J Babol Univ Med Sci 2014; 16 (2) :23-28
URL: http://jbums.org/article-1-4640-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 16, Issue 2 (2-2014) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.06 seconds with 43 queries by YEKTAWEB 4645